Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  PAREXEL International Corporation    PRXL

Delayed Quote. Delayed  - 07/22 10:00:00 pm
65.19 USD   +0.96%
07/11 PAREXEL : Announces Date of Fourth Quarter and Fiscal Year 2016 Earn..
06/30 PAREXEL : Outlines Growth Strategy and Updates Financial Guidance at..
06/20 PAREXEL : Experts to Discuss Key Drug Development Insights at DIA 20..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo PAREXEL International Corp
Provides clinical research and development services

PAREXEL International Corp. is a biopharmaceutical services company.

It provides clinical research, medical communications, consulting, commercialization and informatics, and technology services to pharmaceutical, biotechnology, and medical device industries.

The company operates through the following segments: Clinical Research Services, PAREXEL Consulting Services and PAREXEL Informatics.

The Clinical Research Services segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, date management and biostatistics, epidemiology and health economics/outcomes research, clinical logistics, pharmacovigilance, clinical pharmacology, and related medical affiairs, patient recruitment and investigator site services.

The PAREXEL Consulting Services segment provides technical expertise and advice in drug development, regulatory affairs, and good manufacturing practice compliance consulting.

The PAREXEL Informatics segment provides information technology solutions designed to improve client's product development processes.

PAREXEL International was founded by Josef H. von Rickenbach and Anne B. Sayigh in 1983 and is headquartered in Waltham, MA.

Number of employees : 18 660 persons.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Clinical Research Services1,45564.2%1,53565.8% +5.5%
PAREXEL Informatics267.9011.8%264.6711.3% -1.21%
PAREXEL Consulting Services216.189.5%215.959.3% -0.11%
Sales per Regions
20142015Delta
USD (in Million)%USD (in Million)%
The Americas970.8942.8%70.903% -92.7%
Europe, Middle East & Africa709.1431.3%451.4619.4% -36.34%
Asia/Pacific259.3311.4%269.3011.5% +3.84%
United States--984.6842.2%-
United Kingdom--239.6510.3%-
Managers
NameAgeSinceTitle
Josef H. von Rickenbach, MBA611983Chairman & Chief Executive Officer
Mark A. Goldberg, MD551997President & Chief Operating Officer
Emma Reeve552014Chief Financial Officer, VP & Controller
Roland Andersson, PhD522014Senior Vice President-Clinical Research Services
Sy Pretorius MD, MBA--Chief Scientific Officer & Vice President
A. Dana Callow Jr., MBA641986Independent Director
Patrick J. Fortune PhD, MBA691996Independent Director
Richard L. Love722002Independent Director
Ellen M. Zane642006Independent Director
Christopher J. Lindop, CPA572006Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 52,887,809 51,935,772 98.2% 0 0.0% 98.2%
Shareholders
NameEquities%
BlackRock Fund Advisors 4,475,657 8.46%
The Vanguard Group, Inc. 4,270,284 8.07%
UBS Financial Services, Inc. 2,483,293 4.70%
Wellington Management Co. LLP 2,360,422 4.46%
Fisher Asset Management LLC 2,337,002 4.42%
Frontier Capital Management Co. LLC 1,976,198 3.74%
SSgA Funds Management, Inc. 1,749,294 3.31%
Neuberger Berman Investment Advisers LLC 1,430,032 2.70%
Acadian Asset Management LLC 1,311,469 2.48%
Northern Trust Investments, Inc. 1,066,469 2.02%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
PAREXEL INTERNATIONAL ..-4.30%3 448
INCYTE CORPORATION-20.32%16 212
CELLTRION, INC.--.--%10 689
LONZA GROUP AG9.44%9 737
QUINTILES TRANSNATIONA..7.82%8 859
ALKERMES PLC-37.26%7 528
SEATTLE GENETICS, INC.-1.98%6 166
ALNYLAM PHARMACEUTICAL..-30.43%5 590
QIAGEN NV-16.56%5 530
UNITED THERAPEUTICS CO..-28.86%4 963
ACADIA PHARMACEUTICALS..2.52%4 136
BIO-TECHNE CORP23.06%4 121
CHARLES RIVER LABORATO..7.95%4 094
ICON PLC-7.16%3 972
IONIS PHARMACEUTICALS ..-55.05%3 363
INTREXON CORP-20.36%2 837
LIGAND PHARMACEUTICALS..22.26%2 760
PRA HEALTH SCIENCES IN..-2.32%2 678
GALAPAGOS-16.05%2 422
INC RESEARCH HOLDINGS ..-12.08%2 313
HANGZHOU TIGERMED CONS..--.--%2 071
Sector Biotechnology & Medical Research - NEC
PAREXEL International Corp : Connections
Applied Microarrays, Inc.
Harvard T.H. Chan School of Public Health
Agnovos Healthcare LLC
MedAptus, Inc.
Molecular Profiling Institute, Inc.
Tufts University
Jobs for Massachusetts, Inc.
New England Healthcare Institute
PHT Technologies, Inc.
Caris Molecular Profiling Institute, Inc.
TVP Management Co. LLC
The Leukemia & Lymphoma Society, Inc.
CardioMEMS, Inc.
Press Ganey Associates, Inc.
GlycoFi, Inc.
Association of Clinical Research Organizations
Epigenesis Pharmaceuticals LLC
MedTrust Online LLC
Sapphire Therapeutics, Inc.
Ascalon International, Inc.
University of Wisconsin Foundation
Syndevrx, Inc.
University of Illinois
PMed Management LLC
PAREXEL International Ltd.
Translational Accelerators LLC
The Floating Hospital, Inc.
Minuteman Health, Inc.
Cleveland Clinic
Sun Mountain Capital LLC
Cleveland Clinic Innovations
Century Capital Management, Inc.
CerRx, Inc.
George Washington University
Cancer Prevention Pharmaceuticals Inc
Global Med Technologies, Inc.
Company contact information
PAREXEL International Corp.
195 West Street
Waltham, MA 02451

Phone : +1.781.487.9900
Fax : +1.781.487.0525
Web : www.parexel.com
© 2016 People , Fundamentals and Ownership